THE LATEST
APR 2026 · Stratus signs UK distribution agreement with OsteotecFEB 2026 · $10 million Series B announcedTHE PROFILE · Bret Boudousquie and the business of starting again

People / Founders & operators

Bret Boudousquie and the business of starting again

Before co-founding Stratus Medical, Bret Boudousquie learned lending, selling and the work of rebuilding a company. His next chapter brought those experiences together - and gave him more reasons to stay in Houston.

Advertisement

Bret Boudousquie had a banking career before he had a company to finance. At Wachovia, he worked as a commercial lender, learning how businesses behave when their plans meet their accounts. Years later, he would be on the other side of the conversation, helping assemble the capital to acquire a business and build Stratus Medical. It is a pleasing reversal: the former lender arriving with a proposition of his own.

His education was in business administration, with a focus on finance, at the University of North Carolina Wilmington. The vocabulary of his subsequent career expanded to include sales, marketing, manufacturing and product development. Finance remained part of the job. By February 2026, Stratus had announced a $10 million Series B led by Wasatch Health Partners, an existing financial partner. The early banking chapter had acquired a practical sequel.

Boudousquie is Stratus’s co-founder and chief executive. The company is headquartered in Magnolia, Texas, within the Houston area he has called home for more than two decades. His route there runs through a large corporation, smaller businesses, a company sale and another beginning. The interesting part is how much experience he carried into that beginning. Starting again, in his case, came with a considerable amount of prior homework.

Four years before the next beginning

After banking came Johnson & Johnson, then startup companies. Boudousquie’s responsibilities included sales, marketing and sales management. These jobs put him close to the commercial work of explaining a product, winning business and organizing the people responsible for doing both. They also placed him inside organizations of different sizes. A large employer and a young company can give the same executive quite different educations.

At RadiaDyne, he became president. During his four-year tenure, the team updated its products, systems and processes. In early 2018, it launched OARtrac, a product that received industry recognition. RadiaDyne was sold that September. Those dates give his next venture a useful prehistory: before taking charge of Nimbus in July 2019, he had already helped take a business through operational changes, a launch and a sale.

Former colleagues have described the everyday side of his leadership. Sabrina Gooden, who worked with him at RadiaDyne, credited the time he invested in her and the support he offered. John Isham highlighted his communication with suppliers and his ability to explain expectations to a sales team. Their accounts put some detail around an executive title: the work included helping other people understand the assignment and feel able to carry it out.

The scope of that work matters. Products, systems and processes make an unglamorous trio on a page, yet they describe much of what a company actually is. A launch depends on people knowing their jobs and the organization being able to deliver. Boudousquie’s earlier assignment had involved that whole apparatus. The next one would ask him to organize around an existing product and expand its commercial presence.

A career in transitionsExperience travels with him.
  1. Before 2019Commercial banking, sales and management; president of RadiaDyne.
  2. July 2019Becomes CEO of Nimbus.
  3. December 2019Founds Stratus Medical.
  4. January 2020Stratus announces financing and the NimbusRF acquisition.
  5. February 2026Stratus announces a $10 million Series B.

An acquisition, and a first believer

His Nimbus appointment began in July 2019. The brief covered American commercialization, international expansion and continued product development. Stratus followed later that year: his July 2024 interview biography dates its founding to December 2019. The following January, the new company announced a private placement and the acquisition of NimbusRF assets from Biomerics. Med Venture Holdings led the investment.

That sequence gives the founding story its particular shape. Nimbus existed before Stratus. Boudousquie’s opportunity was to put a new business around it, with financing for expansion and further development. Ownership, capital and commercial responsibility came together. The company began with an acquisition to execute and a market to serve, which makes for a rather different opening scene from the customary sketch on a napkin.

There was also Cody Jorgensen. Boudousquie has described him as the first team member, someone who left a good job and joined before Stratus was formed. Jorgensen later became director of marketing. That small detail adds a person to the transaction history. Before there was a settled organization, another employee had decided to take the chance. Years later, the founder still singled out that decision when speaking about him.

Houston, with two airports attached

In March 2025, Boudousquie joined a founder panel at the Houston Med Tech Rodeo. The question was why the panelists had established their businesses in Texas. His answer reached back 22 years, to the management role at Johnson & Johnson that brought him and his family to Houston. The Texas Medical Center had been the catalyst for the move. Staying became a separate decision.

His reasons included talented workers, two large international airports, established industry infrastructure, research universities and an evolving innovation culture. He also included the mild winter and cost of living. It was a founder’s answer with room for the household budget. An airport helps a business reach the world; an agreeable winter helps explain why the person running it might be happy to come home.

Texas A&M, Rice, the University of Houston, SMU and the University of Texas all appeared in his account of the state’s research strengths. His case for Houston combined people, institutions and connections. It also makes the company’s international ambitions easier to place geographically. Magnolia is the headquarters; the wider region supplies a network that reaches well beyond the office. His account of staying is a collection of practical reasons accumulated over time.

Bret Boudousquie, seated in the center, speaking into a microphone during a Houston founder panel
A good place to stay. Boudousquie, center, discussing the Texas choice at the Houston Med Tech Rodeo in 2025. Photo: Stratus Medical.

The introductions keep coming back

From April 2018 to December 2024, Boudousquie served as a pro bono advisor to TMC Innovation. His stated areas of expertise included commercialization, team building, financing, mergers and acquisitions, product development and contract manufacturing. The list tracks the working parts of his own career. It also shows him making those experiences available to founders while he was still occupied with building a business himself.

Connections recur in his public exchanges. When the MedTech Startup podcast team visited Stratus in The Woodlands in 2023, he recalled meeting Giovanni Lauricella in Sydney in May 2019. The later visit brought Lauricella’s team into the office to discuss fundraising and commercialization with Boudousquie and Jorgensen. A conversation begun in Australia had, several years later, acquired a Texas address.

The advisory role also overlapped with the transition between RadiaDyne and Stratus. Its dates put him in the founder community before his own new company had been formed, then keep him there through several years of its development. That overlap makes the network part of the chronology. He was offering experience from earlier jobs while acquiring new experience that other entrepreneurs might later find useful.

He has also credited Rick Randall as an influence, recalling an early startup opportunity and describing four years of unusually concentrated learning. In a public post about a Houston gathering, Boudousquie said he continued to learn from Randall. There is something useful in seeing an established chief executive still name the people who taught him. Experience can make a person’s biography longer; remembering the teachers gives it some company.

“Great respect for the work and accomplishment!”

Bret Boudousquie, celebrating his team

Three different ways to count progress

By 2024, Stratus had begun appearing on business lists that measured different aspects of its development. Pepperdine Graziadio included it among that year’s Most Fundable Companies and identified Boudousquie as its founder. The assessment considered financial projections, market opportunity, intellectual property, competitive advantage and management expertise. Stratus also received a Fan Favorite designation. The former commercial lender’s company was now being examined for its own investment readiness.

Deloitte’s 2024 Technology Fast 500 recorded Stratus at number 483, with revenue growth of 212 percent over the evaluated three-year period. Put into an index, a starting value of 100 becomes 312. The figure belongs to the company and that measurement period. It provides a concrete marker for the commercial expansion Boudousquie had been hired to pursue in 2019.

The Houston Business Journal recognition followed in 2025, when Stratus joined its Top 300 Private Companies list. Then, in March 2026, the company announced a place at number 45 on Fortune’s America’s Most Innovative Companies list. Fundability, growth, regional scale and innovation are different judgments. Together, the recognitions show how many kinds of questions a growing company eventually has to answer.

The commercial recordWhat 212% growth looks like
Starting revenue
100
End of measured period
312

Revenue indexed to 100 at the start of the three-year period evaluated for Deloitte’s 2024 Technology Fast 500. Index values illustrate reported growth; they are not dollar amounts.

The next chapter has a budget

The February 2026 Series B returned the story to capital. Wasatch Health Partners led the $10 million round through its Growth Fund, following an earlier $25 million convertible debt facility through its Structured Capital platform. These are separate financing arrangements. They describe an investor relationship that continued across different forms of funding as Stratus developed.

In March, Stratus also put a number on its commitment to development: it said it had invested 40 percent of cumulative revenue in product development since 2020. The measure describes the company’s allocation over that period, rather than a single year’s spending. For Boudousquie, whose remit had included development from the Nimbus appointment onward, it supplied another way to describe where resources were going.

The announced uses included product development and expanding and protecting the company’s patent portfolio. Boudousquie thanked Wasatch for the long-term relationship. His wording put continuity near the center of the announcement. For an executive whose founding transaction also depended on outside capital, the ability to keep working with financial partners is a recurring part of the assignment.

Expansion took another form in April 2026, when Osteotec announced an exclusive UK distribution agreement with Stratus. Will Pankey, Stratus’s sales leader, spoke for the company about the partnership. The international brief had become work shared across a leadership team. Boudousquie remained chief executive, with colleagues responsible for global sales, operations, marketing, engineering and quality.

His public enthusiasm often lands on those colleagues. In a post celebrating the sales team’s recognition, he wrote, “Great respect for the work and accomplishment!” It is a brief line, with the exclamation mark firmly employed. After the financing figures, acquisitions and lists, the people reappear. A lender learns to examine a business on paper. Boudousquie’s subsequent career has kept returning him to the people who have to make the paper promises work.

Follow the work

The company, the conversations and the next chapter.